{
  "id": 3955,
  "url": "https://nnemf.org/research/3955-nociceptin-inhibits-electric-field-stimulation-induced-cholinergic-constrictions",
  "title": "Nociceptin inhibits electric field stimulation-induced cholinergic constrictions in rat airways.",
  "authors": [
    "Y Wu",
    "L B Fang",
    "Q H Yang"
  ],
  "journal": "Acta pharmacologica Sinica",
  "year": "2000",
  "doi": null,
  "pmid": "11501050",
  "abstract": "AIM: To study the effect of nociceptin (orphanin FQ), a newly discovered heptadecapeptide, on cholinergic constrictions in isolated trachea and bronchus of rat. METHODS: The electric field stimulation (EFS) induced a monophasic constriction, which was due to an activation of the cholinergic nerves. RESULTS: Nociceptin 0.001-0.1 mumol/L inhibited cholinergic constriction in a concentration-dependent manner. IC50 (95% of confidence limits) were 0.06 (0.04-0.08) mumol/L and 0.07 (0.05-0.1) mumol/L in tracheae and bronchi respectively. The constrictions inhibited by nociceptin 0.01 mumol/L in traheae and bronchi were (58 +/- 32)% and (60 +/- 26)% respectively compared with the control, in which nociceptin was not applied. After pretreatment with naloxone 0.1 mumol/L, the constrictions were (60 +/- 19)% and (54 +/- 20)% (P > 0.05 vs the above figures). However, the constrictions induced by exogenous acetylcholine were unaffected by nociceptin 0.01 mumol/L. kappa-Opioid receptor agonist, U-50488H (0.01-1 mumol/L) did not affect the EFS-induced cholinergic constrictions in rat airways. CONCLUSION: Nociceptin inhibits EFS-induced cholinergic constriction, which is not affected by naloxone in rat airways.",
  "effect": "mixed",
  "evidence": "low",
  "extraction": {
    "studyType": "animal",
    "studyTypeLabel": "Animal study",
    "effectDirection": "mixed",
    "evidenceLabel": "Low",
    "population": "Isolated trachea and bronchus of rat",
    "sampleSize": "—",
    "exposure": "electric field stimulation (EFS)",
    "confidencePct": "74",
    "peerReviewed": "yes",
    "mainFindings": "Electric field stimulation induced a monophasic cholinergic constriction in isolated rat trachea and bronchus. Nociceptin (0.001–0.1 µmol/L) inhibited EFS-induced cholinergic constriction in a concentration-dependent manner; this inhibition was not significantly altered by naloxone pretreatment, and nociceptin did not affect constrictions induced by exogenous acetylcholine. U-50488H did not affect EFS-induced cholinergic constrictions.",
    "outcomes": [
      "Cholinergic constriction in isolated rat trachea and bronchus (EFS-induced)",
      "Response to exogenous acetylcholine",
      "Effect of naloxone pretreatment",
      "Effect of kappa-opioid receptor agonist U-50488H"
    ],
    "limitations": [
      "No EFS parameters reported (e.g.",
      "frequency",
      "field strength",
      "pulse characteristics).",
      "Sample size not reported in abstract.",
      "Ex vivo isolated tissue preparation",
      "generalizability to in vivo physiology not established in abstract.",
      "Focus is pharmacologic modulation of EFS-evoked responses rather than environmental EMF exposure."
    ],
    "keywords": [
      "nociceptin",
      "orphanin FQ",
      "electric field stimulation",
      "EFS",
      "cholinergic nerves",
      "trachea",
      "bronchus",
      "rat",
      "airways",
      "acetylcholine",
      "naloxone",
      "U-50488H"
    ],
    "hubs": [],
    "raw": "{\n  \"study_type\": \"animal\",\n  \"exposure\": {\n    \"band\": null,\n    \"source\": \"electric field stimulation (EFS)\",\n    \"frequency_mhz\": null,\n    \"sar_wkg\": null,\n    \"duration\": null\n  },\n  \"population\": \"Isolated trachea and bronchus of rat\",\n  \"sample_size\": null,\n  \"outcomes\": [\n    \"Cholinergic constriction in isolated rat trachea and bronchus (EFS-induced)\",\n    \"Response to exogenous acetylcholine\",\n    \"Effect of naloxone pretreatment\",\n    \"Effect of kappa-opioid receptor agonist U-50488H\"\n  ],\n  \"main_findings\": \"Electric field stimulation induced a monophasic cholinergic constriction in isolated rat trachea and bronchus. Nociceptin (0.001–0.1 µmol/L) inhibited EFS-induced cholinergic constriction in a concentration-dependent manner; this inhibition was not significantly altered by naloxone pretreatment, and nociceptin did not affect constrictions induced by exogenous acetylcholine. U-50488H did not affect EFS-induced cholinergic constrictions.\",\n  \"effect_direction\": \"mixed\",\n  \"limitations\": [\n    \"No EFS parameters reported (e.g., frequency, field strength, pulse characteristics).\",\n    \"Sample size not reported in abstract.\",\n    \"Ex vivo isolated tissue preparation; generalizability to in vivo physiology not established in abstract.\",\n    \"Focus is pharmacologic modulation of EFS-evoked responses rather than environmental EMF exposure.\"\n  ],\n  \"evidence_strength\": \"low\",\n  \"confidence\": 0.74,\n  \"peer_reviewed_likely\": \"yes\",\n  \"keywords\": [\n    \"nociceptin\",\n    \"orphanin FQ\",\n    \"electric field stimulation\",\n    \"EFS\",\n    \"cholinergic nerves\",\n    \"trachea\",\n    \"bronchus\",\n    \"rat\",\n    \"airways\",\n    \"acetylcholine\",\n    \"naloxone\",\n    \"U-50488H\"\n  ],\n  \"suggested_hubs\": []\n}"
  },
  "synthesis": null,
  "synthesisStatus": "pending",
  "originalHref": "https://pubmed.ncbi.nlm.nih.gov/11501050/",
  "sourceUrl": "https://rfsafe.org/mel/paper.php?id=3955",
  "updated": "2026-02-13 07:44:43"
}